FDA Moves On Novartis Gene Therapy May Be Good For Kite Pharma – Barron’s


Barron's
FDA Moves On Novartis Gene Therapy May Be Good For Kite Pharma
Barron's
A Food And Drug Administration panel is expected to meet tomorrow to discuss Novartis's (NVS) experimental gene therapy drug, a move that could be good news for Kite Pharma (KITE), according to Canaccord Genuity. Illustration: Getty Images/iStockphoto.
FDA Decision on Novartis Gene Therapy Drug Could Benefit Kite PharmaTheStreet.com

all 77 news articles »

Visit link:

FDA Moves On Novartis Gene Therapy May Be Good For Kite Pharma - Barron's

Related Posts

Comments are closed.